InvestorsHub Logo

Canoepaddler

11/23/15 1:29 PM

#2121 RE: buckiii2 #2118

Fantastic news,..a baby $ISIS IMO.

Citrati

11/23/15 1:52 PM

#2122 RE: buckiii2 #2118

Best part IMO is "selected molecules".
Opportunity for an entire platform. and multiple license agreements/partnerships if desired or funding to keep platform moving forward.

north40000

11/23/15 6:43 PM

#2124 RE: buckiii2 #2118

Is this a problem? or another collaboration?:

FDA approves Opdivo monotherapy for second-line RCC:

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm473971.htm